26 February 2021 | News
For the development of new technologies to improve diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19
Image credit- shutterstock.com
The Australian Government is investing $100 million into the development of new technologies to improve diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19.
The funding will be split across three research projects led by senior researchers at the University of Melbourne, the Australian Lung Health Initiative, and Florey Institute of Neuroscience and Mental Health.
The five year funding is being provided under Stage Two of the Frontier Health and Medical Research Initiative, an unprecedented program which allows researcher collaborations to explore the most bold and exciting ideas that could have a dramatic, global impact on health care.
The successful projects were chosen from 10 applicants, which each received up to $1.5 million in funding to develop ground-breaking ideas into research plans. The research plans were then assessed by an independent committee of Australian and international experts.
The selected projects are: